Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Meeting Report of the Technical Education Committee Symposium: Management of DNA reactive (mutagenic) impurities in drug development
Ist Teil von
PDA Journal of GMP and Validation in Japan, 2021, Vol.23(1), pp.1-12
Ort / Verlag
Parenteral Drug Association Japan Chapter
Erscheinungsjahr
2021
Link zum Volltext
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
The Technical Education Committee Symposium, Management of DNA reactive (mutagenic) impurities in drug development, sponsored by the Parenteral Drug Association (PDA) Japan Chapter, was held online on November 5, 2020. The symposium focused on the control of mutagenic impurities per ICH M7, and the speakers presented calculation methods and operational challenges regarding the use of purge factor calculations during the application of Option 4. In this symposium, risk assessment of nitrosamine impurities, which have recently become a significant issue in pharmaceutical quality control, was also a key topic. This article summarizes the presentation of each speaker at the symposium.